We're upgrading our full protein catalog to ultra-low endotoxin levels.
KACTUS is continually committed to exceptional quality. That's why are taking the initiative to upgrade our entire recombinant protein catalog to endotoxin levels < 0.01 EU/μg or even < 0.001 EU/μg.
We are completing this catalog upgrade with no compromise on performance – just cleaner, more reliable proteins tailored to your drug development needs.
Animal immunization
ELISA or other analytical assays assays requiring low endotoxin
Cell-Based Assays
Preclinical studies that demand precise, reproducible data
Browse our current low-endotoxin catalog product list
For all low-endotoxin catalog proteins, we guarantee endotoxin levels <0.01 EU/ug
For more strict endotoxin control, please contact us at sales@kactusbio.us.
Features of KACTUS Low Endotoxin Proteins
→ Ultra-Low Endotoxin: Endotoxin levels <0.01 or <0.001 EU/μg—surpassing industry standards and minimizing the risk of immune interference.
→ High Purity: >90% purity confirmed by Tris-Bis PAGE for consistent performance.
→ Stringent Quality Control: Every lot is tested for purity and endotoxin content to ensure batch-to-batch consistency.
Advantages of KACTUS Low Endotoxin Proteins
→ Immunization-Ready: Suitable for animal immunogenicity studies and injections, reducing the risk of endotoxin-driven inflammatory responses.
→ Assay-Compatible: Optimized for ELISA and flow cytometry—minimizing background signal by reducing endotoxin interference with antigen–antibody binding.
Why choose KACTUS for low endotoxin proteins?
Catalog & Custom Services
Down to <0.001 EU/ug
Mammalian Expression
Large Scale Production Facilities
Custom Low Endotoxin Protein Expression Services
KACTUS offers custom recombinant protein expression services tailored to meet stringent endotoxin requirements for preclinical and immunotherapy research. Our optimized expression systems—paired with purification workflows designed to minimize endotoxin contamination—enable the production of high-purity proteins with endotoxin levels as low as <0.001 EU/μg. Whether for animal immunization, functional assays, or preclinical studies, we deliver high-quality proteins expressed in optimized systems and rigorously purified to meet strict endotoxin specifications—ensuring both biological activity and compatibility with sensitive applications.
To request custom ultra-low endotoxin proteins, please contact your sales representative or reach out to us at sales@kactusbio.us.
Importance of endotoxin control in antibody drug discovery
Endotoxins are lipopolysaccharides (LPS) found in the cell walls of Gram-negative bacteria. During recombinant protein production, endotoxins are typically introduced when using prokaryotic expression systems such as E. coli, or from prokaryotic-derived plasmids.
High endotoxin levels in recombinant proteins can compromise multiple stages of the antibody discovery process, including:
- Animal immunization, where endotoxins may induce inflammatory responses, dysregulate the immune system, and result in low antibody titers or increased production of non-specific antibodies.
- In vitro screening such as ELISA or flow cytometry, where endotoxins can interfere with antigen–antibody interactions, leading to high background noise and reduced screening accuracy.
Endotoxins are heat-stable and resistant to conventional removal methods such as heat treatment, making them particularly challenging to eliminate. Effective control of endotoxin requires interventions at every step—from expression system design to downstream purification.
At KACTUS, we are committed to elevating protein quality by optimizing expression conditions and refining purification workflows. This allows us to consistently achieve ultra-low endotoxin levels, reducing the risk of immune interference and better fulfilling the stringent needs of animal immunization and preclinical drug development.
60 Hickory Drive
Waltham, MA 02451
United States
Ultra-Low Endotoxin Recombinant Proteins | KACTUS